MARKET

BIO

BIO

Bio Rad Labs Inc
NYSE
319.42
+4.25
+1.35%
After Hours: 318.78 -0.64 -0.20% 18:42 07/26 EDT
OPEN
316.10
PREV CLOSE
315.17
HIGH
323.56
LOW
313.96
VOLUME
243.35K
TURNOVER
0
52 WEEK HIGH
431.79
52 WEEK LOW
261.59
MARKET CAP
9.11B
P/E (TTM)
-30.8434
1D
5D
1M
3M
1Y
5Y
1D
Agree To Purchase Bio-Rad Laboratories At $280, Earn 8.2% Annualized Using Options
NASDAQ · 2d ago
Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?
NASDAQ · 4d ago
Weekly Report: what happened at BIO last week (0715-0719)?
Weekly Report · 4d ago
What You Need to Know Ahead of Bio-Rad Laboratories' Earnings Release
Bio-Rad Laboratories, Inc. Is set to announce its fiscal Q2 earnings results after the market closes on Thursday, Aug. 1. The company is known for its innovative products and solutions in scientific research and clinical diagnostics. BIO’s shares declined 4.2% following the company's Q1 earnings release.
Barchart · 07/19 13:53
Bio-Rad Laboratories, Inc.'s (NYSE:BIO) Shares May Have Run Too Fast Too Soon
Bio-Rad Laboratories, Inc.'s price-to-sales ratio of 3.5x is similar to the median for the Life Sciences industry in the U.S. The company has been struggling to grow its revenue faster than other companies. The median P/S for the industry is expected to grow by 6.9% over the next three years.
Simply Wall St · 07/18 17:32
Press Release: Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024
Dow Jones · 07/17 20:36
Bullish Two Hundred Day Moving Average Cross - BIO
NASDAQ · 07/16 19:56
Incyte, Moderna among most shorted S&P 500 healthcare stocks in June
Seeking Alpha · 07/16 17:01
More
About BIO
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Webull offers Bio Rad Laboratories Inc stock information, including NYSE: BIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIO stock methods without spending real money on the virtual paper trading platform.